Peter W Schiller

Years Active: 2020-2022
Publications (10 Years): 6

Institut de recherches cliniques de Montréal

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Institut de recherches cliniques de Montréal Feb 3o 1975

Canada

Professor and Lab Director :: Chemical biology and peptide research

Publications

Kensaku Itoh, Megumi Shimoyama, Peter W Schiller, Satoshi Toyama
Protective effect of a mitochondria-targeting peptide against paclitaxel-induced peripheral neuropathy. Chemical biology & drug design 101 (4) (2022)
Kensaku Itoh, Megumi Shimoyama, Peter W Schiller, Satoshi Toyama
Protective effect of a mitochondria-targeting peptide against paclitaxel-induced peripheral neuropathy. Chemical biology & drug design 101 (4) (2022)
Kensaku Itoh, Megumi Shimoyama, Peter W Schiller, Satoshi Toyama
Protective effect of a mitochondria-targeting peptide against paclitaxel-induced peripheral neuropathy. Chemical biology & drug design 101 (4) (2022)
Kensaku Itoh, Megumi Shimoyama, Peter W Schiller, Satoshi Toyama
Protective effect of a mitochondria-targeting peptide against paclitaxel-induced peripheral neuropathy. Chemical biology & drug design (2022)
Jordan D Lewicky, Nya L Fraleigh, Alexandrine L Martel, Thi M-D Nguyen, Peter W Schiller, Leila Mousavifar, René Roy, Anh Dzung Le, Douglas Funk, Hoang-Thanh Le
Improving the Utility of a Dynorphin Peptide Analogue Using Mannosylated Glycoliposomes. International journal of molecular sciences 22 (15) (2021)
Saijian Shi, Jian Xu, LingLing Feng, Xin Fan, Zhen Chen, Yajuan Qin, Nga N Chung, Tingyou Li, Peter W Schiller
Novel µ opioid antagonists derived from the µ opioid agonists endomorphin and [Dmt1 ]DALDA (H-Dmt-D-Arg-Phe-Lys-NH2 ). Chemical biology & drug design 96 (5) (2020)

Peter W Schiller.css-eqlu8i{font-size:small;padding-left:4px;}